Share This Article:

Neurolymphomatosis: A Rare Cause of Multiple Mononeuropathy

Full-Text HTML Download Download as PDF (Size:1230KB) PP. 190-193
DOI: 10.4236/wjns.2014.42022    4,029 Downloads   5,067 Views   Citations

ABSTRACT

Neurolymphomatosis, defined as invasion of cranial nerves and peripheral nerve roots, plexus or nerves by Non Hodgkin’s Lymphoma is a very rare clinical entity. We describe a case of 69 years old gentleman, who presented to us with asymmetric, painful sensorimotor polyneuropathy. He was admitted with 2 months history of dry cough, constitutional symptoms, paraesthesias on right side of face along with painful asymmetrical quadriparesis. Nerve conduction studies were suggestive of asymmetrical sensorimotor axonal and demyelinating neuropathy. Cerebrospinal fluid analysis revealed mild pleocytosis with raised protein. FDG-PET showed intense uptake in both adrenals, abdominal lymph nodes, sacral nerve roots and brachial plexus. Fine needle aspiration cytology of adrenal mass revealed evidence of diffuse large B cell Non Hodgkin’s Lymphoma. As patient succumbed to illness, an autopsy was done, which revealed diffuse large B cell lymphoma involving adrenals, brachial and lumbosacral plexuses. Our report provides important insights into a rare cause of painful demyelinating multiple mononeuropathy and emphasises on increasing role and diagnostic utility of PET imaging in evaluation of patients presenting with multiple mononeuropathy, especially with regards to paraneoplastic or neoplastic causes such as lymphoma.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Petluri, G. , Goyal, M. , Singla, V. , Mittal, B. , Nahar, U. , Modi, M. , Gupta, N. and Khurana, D. (2014) Neurolymphomatosis: A Rare Cause of Multiple Mononeuropathy. World Journal of Neuroscience, 4, 190-193. doi: 10.4236/wjns.2014.42022.

References

[1] Giglio, P. and Gilbert, M.R. (2006) Neurologic Complications of Non-Hodgkin’s Lymphoma. Current Hematologic Malignancy Reports, 1, 214-219. http://dx.doi.org/10.1007/s11899-006-0002-y
[2] Baehring, J.M. and Batchelor, T.T. (2012) Diagnosis and Management of Neurolymphomatosis. Cancer Journal, 18, 463-468. http://dx.doi.org/10.1097/PPO.0b013e31826c5ad5
[3] Gan, H.K., Azad, A., Cher, L. and Mitchell, P.L. (2010) Neurolymphomatosis: Diagnosis, Management and Outcomes in Patients Treated with Rituximab. Neuro-Oncology, 12, 212-215. http://dx.doi.org/10.1093/neuonc/nop021
[4] Tomita, M., Koike, H., Kawagashira, Y., Iijima, M., et al. (2013) Clincopathological Features of Neuropathy Associated with Lymphoma. Brain, 136, 2563-2578. http://dx.doi.org/10.1093/brain/awt193
[5] Salm, L.P., Van der Hiel, B. and Stokkel, M.P. (2012) Increasing Importance of 18F-FDG PET in the Diagnosis of Neurolymphomatosis. Nuclear Medicine Communications, 33, 907-916. http://dx.doi.org/10.1097/MNM.0b013e3283561881
[6] Suga, K., Yasuhiko, K., Matsunaga, N., Yujiri, T., Nakazora, T. and Ariyoshi, K. (2011) F-18 FDG PET/CT Findings of a Case of Sacral Nerve Root Neurolymphomatosis That Occurred during Chemotherapy. Clinical Nuclear Medicine, 36, 73-76. http://dx.doi.org/10.1097/RLU.0b013e3181f4a03f
[7] Cheson, B.D. (2011) Role of Functional Imaging in the Management of Lymphoma. Journal of Clinical Oncology, 29, 1844-1854. http://dx.doi.org/10.1200/JCO.2010.32.5225

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.